Finding LCX AMI With Posterior ECG LeadS

Overview

Along with symptoms of chest pain, the presence of ST segment elevations on ECG is the criterion usually used in practice to identify patients with acute coronary artery occlusion and is essential for the direct and acute referral of patients for primary PCI. However, ECG does not always reflect changes in the posterior wall of the heart, often equivalent to the left circumflex coronary artery's (LCX) supply area, resulting in an underrepresentation of LCX as culprit artery in STEMI populations. There is a general concern that some patients with genuine acute occlusion of LCX may present without ST segment elevation and be denied reperfusion therapy, resulting in larger infarction and worse outcome. The aim of this trial is to implement record of posterior ECG leads (V7, V8 and V9) in addition to the standard 12-lead ECG in the pre-hospital setting and to evaluate the clinical impact of this implementation: In comparison to a control cohort of STEMI patients diagnosed with a pre-hospital standard 12-lead ECG prior study start, the investigators hypothesize that introducing V7-V9 leads as a clinical routine in the pre-hospital setting will identify patients with STEMI involving LCX and with a non-diagnostic standard 12-lead ECG.

Full Title of Study: “Clinical Impact of Pre-hospital Posterior ECG Leads Implementation for Identifying Occlusion of Left Circumflex Coronary Artery in ST Segment Elevation Myocardial Infarction”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Other
  • Study Primary Completion Date: August 31, 2019

Interventions

  • Other: Standard 12-Lead ECG
    • Conventional record of Standard 12-lead ECG in every patient with suspect of acute coronary syndrome.
  • Other: Posterior ECG Leads
    • Recording posterior ECG leads (V7, V8 and V9) in addition to standard 12-lead ECG for identifying STEMI involving left cirumflex coronary artery.

Arms, Groups and Cohorts

  • Control
  • Intervention

Clinical Trial Outcome Measures

Primary Measures

  • Proportion of patients with LCX occlusion as culprit artery in the intervention group compared to the control group
    • Time Frame: Day one – culprit lesion treated with primary PCI

Secondary Measures

  • Proportion of patients in the intervention group with STEMI involving LCX artery, non-diagnostic standard 12-lead ECG and ST segment elevation >0,5 mm in ≥2 leads in posterior ECG leads (V7-V9).
    • Time Frame: Day one – culprit lesion treated with primary PCI

Participating in This Clinical Trial

Inclusion Criteria

Intervention group:

  • All STEMI patients referred directly from the pre-hospital setting, treated with primary PCI and with available standard 12-lead ECG and ECG with V7-V9 leads. Exclusion Criteria:

  • STEMI patients treated with primary PCI and no ECG with V7-V9 leads.

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Rigshospitalet, Denmark
  • Collaborator
    • Nykøbing Falster County Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: Yama Fakhri, MD – Rigshospitalet, Denmark
  • Overall Official(s)
    • Jens Kastrup, MD,Professor, Study Chair, Dept of Cardiology, Rigshospitalet, Copenhagen, Denmark
  • Overall Contact(s)
    • Yama Fakhri, MD, +4535451196, yama.said.fakhri@regionh.dk

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.